These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11166886)

  • 1. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid.
    Eastcott JW; Holmberg CJ; Dewhirst FE; Esch TR; Smith DJ; Taubman MA
    Vaccine; 2001 Feb; 19(13-14):1636-42. PubMed ID: 11166886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.
    Diwan M; Tafaghodi M; Samuel J
    J Control Release; 2002 Dec; 85(1-3):247-62. PubMed ID: 12480329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
    McCluskie MJ; Davis HL
    Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.
    McCluskie MJ; Weeratna RD; Davis HL
    Vaccine; 2001 Mar; 19(17-19):2657-60. PubMed ID: 11257405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG DNA is an effective oral adjuvant to protein antigens in mice.
    McCluskie MJ; Weeratna RD; Krieg AM; Davis HL
    Vaccine; 2000 Nov; 19(7-8):950-7. PubMed ID: 11115721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
    Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN.
    Gill RF; Montgomery PC
    Curr Eye Res; 2002 Mar; 24(3):228-33. PubMed ID: 12221533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of skeletal unloading on the antibody repertoire of tetanus toxoid and/or CpG treated C57BL/6J mice.
    Rettig TA; Bye BA; Nishiyama NC; Hlavacek S; Ward C; Pecaut MJ; Chapes SK
    PLoS One; 2019; 14(1):e0210284. PubMed ID: 30653556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
    Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
    J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice.
    Moran MC; Bence AR; Vallecillo MFS; Lützelschwab CM; Rodriguez MG; Pardo R; Goldbaum FA; Zylberman V; Palma SD; Maletto BA; Estein SM
    Res Vet Sci; 2021 Mar; 135():217-227. PubMed ID: 33631456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.
    Barisani-Asenbauer T; Inic-Kanada A; Belij S; Marinkovic E; Stojicevic I; Montanaro J; Stein E; Bintner N; Stojanovic M
    PLoS One; 2013; 8(4):e60682. PubMed ID: 23637758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
    Gallichan WS; Woolstencroft RN; Guarasci T; McCluskie MJ; Davis HL; Rosenthal KL
    J Immunol; 2001 Mar; 166(5):3451-7. PubMed ID: 11207303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
    Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodeoxynucleotides containing CpG motifs induce low levels of TNF-alpha in human B lymphocytes: possible adjuvants for Th1 responses.
    Bohle B; Orel L; Kraft D; Ebner C
    J Immunol; 2001 Mar; 166(6):3743-8. PubMed ID: 11238615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan.
    Maitta RW; Datta K; Pirofski LA
    Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
    Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
    Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.